| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Verrica Pharmaceuticals Inc. | Director | Common Stock | 20 | $13 | $0.6500 | 31 Mar 2025 | Direct |
| Verrica Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 20,000 | 05 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VRCA | Verrica Pharmaceuticals Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:45 |
| VRCA | Verrica Pharmaceuticals Inc. | 31 Mar 2025 | 1 | $0 | 4 | Director | 02 Apr 2025, 16:32 |
| VRCA | Verrica Pharmaceuticals Inc. | 31 Mar 2025 | 0 | $0 | 3 | Director | 02 Apr 2025, 16:31 |